CENTER ON BEHAVIORAL MEDICINE

BODY-MIND CONNECTION

BEHAVIORAL GENETICS

Behavioral Genetics:  Research Article

Behavioral Genetics Menu

Hormones and Depression in Women

CITATION:  Studd, S.J., Panay, N.  (2004)  Hormones and Depression in Women.  Climacteric. Boca Raton: Dec 2004. Vol. 7, Iss. 4;  pg. 338, 9 pgs.

ABSTRACT:  The biological plausibility for the effect of sex hormones on the central nervous system is now supported by a considerable amount of clinical data. This critical review guides the reader through the plethora of data, from the earliest reports of menstrual madness in the nineteenth century to neurobiological work in the new millennium. It illustrates through the scientific evidence base that, although the effect of estrogen on the central nervous system, particularly on mood and depression, remains a controversial area, there is now considerable evidence for the psychotherapeutic benefits of estrogens in the triad of hormone-responsive depressive disorders: postnatal depression, premenstrual depression and perimenopausal depression. The article also reviews the compelling data that testosterone supplementation has positive effects for depression, libido and energy, particularly where patients have only partially responded to estrogen therapy. 

References

1. Panay N, Studd JWW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998; 5:353-65

2. Freeman MP, Keck PE Jr, McElroy SL. Postpartum depression with bipolar disorder. Am J Psychiatry 2001;158:652

3. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-9

4. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen-receptor beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution. J Comp Neurol 2003;466:251-77

5. Crowley WR. Effects of ovarian hormones on norepinephrine and dopamine turnover in individual hypothalamic and extrahypothalamic nuclei. Neuroendocrinology 1982;34:3816

6. Sherwin B. Hormones, mood and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20-6

7. Moses EL, Drevets WC, Smith G, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 2000;48:854-60

8. Maudsley H. Sex in mind and education. Fortnightly Rev 1874

9. Battey R. Battey's operation - its matured results. Trans Georgia Med Assoc 1873

10. Longo LD. The rise and fall of Battey's operation: a fashion in surgery. Bull Hist Med 1979;53:244-67

11. Frank RT. The hormonal basis of premenstrual tension. Arch Neurol Psychiatry 1931;26:1053-7

12. Greene R, Dalton K. The premenstrual syndrome. Br Med J 1953;1:1007-14

13. Halbriech U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impact and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;S3:1-23

14. Studd JWW. Premenstrual tension syndrome. Br Med J 1979;1:410

15. Backstrom T, Boyle H, Baird DT. Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaecol 1981;88: 530-6

16. Studd JWW. Prophylactic oophorectomy at hysterectomy. Br J Obstet Gynaecol 1989;96: 506-9

17. Leather AT, Studd JWW, Watson NR, Holland EFN. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13:48-55

18. Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated  with GNRH analogues with 'add back' estrogen therapy. Obstet Gynecol 1993; 81:104-7

19. Di Carlo C, Palomba S, Tommaselli GA, Guida M, Di Spiezo Sardo A, Nappi C. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001;76:850-2

20. Sundstrom I, Myberg S, Bixo M, Hammarback S, Backstrom T. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999;78:891-9

21. O'Brien PM, Abukhalil IE. Randomized controlled trial of themanagement of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999;180:18-23

22. Greenblatt RB, Asch RH, Mahesh VB, Bryner JR. Implantation of pure crystalline pellets of estradiol for conception control. Am J Obstet Gynecol 1977;127:520-7

23. Magos AL, Brewster H, Singh R, O'Dowd T, Brincat M, Studd JWW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93: 1290-6

24. Studd JWW, Domoney C, Khastgir G. The place of hysterectomy in the treatment of menstrual disorders. In O'Brien PMS, Cameron I, MacLean A, eds. Disorders of the Menstrual Cycle. London: RCOG Press, 2000;29:313-32

25. Magos AL, Brewster L, Singh R, O'Dowd T, Brincat M, Studd JWW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93: 1290-6

26. Bjorn I, Backstrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32:77-86

27. Panay N, Studd JWW. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71

28. Watson NR, Studd J WW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;23:730-2

29. Smith RNH, Studd JWW, Zambleera D, Holland EFN. A randomised comparison over 8 months of 100 meg and 200 meg twice weekly doses in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 1995;102:6475-84

30. Montgomery JC, Brincat M, Tapp A, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;I:297-9

31. Gregoire AJP, Kumar R, Everitt B, Henderson A, Studd JWW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;3347:930-3

32. Khastgir G, Studd JWW. Patients outlook., experience and satisfaction with hysterectomy, bilateral oophorectomy and subsequent continuation of hormone replacement therapy. Am J Obstet Gynecol 2000;183:1427-33

33. Cronje WH, Vashist A, Studd JWW. Hysterectomy and bilateral oophorectomy for severe pre-menstrual syndrome. Hum Reprod 2004;19: 2152-5

34. Lawrie TA, Hofmeyr GJ, De Jager M, et al. A double blind randomised placebo controlled study of postnatal norethisterone enanthate: the effect on postnatal depression and hormones. Br J Obstet Gynaecol 1998;105:1082-90

35. Ahokas A, Kaukoranta J, Wahlbeck K, et al. Oestrogen deficiency in severe postpartum depression. Successful treatment with sublingual physiologic 17 beta oestradiol: a preliminary study. J Clin Psychiatry 2001;62:332-6

36. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of denerbal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;57:924-30

37. Hunter MS. Depression and the menopause. Br Med J 1996;313:1217-18

38. Morrison MF, Kalian MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized controlled trial. Biol Psychiatry 2004;55:406-12

39. Utian W. The true clinical features of postmenopause and oophorectomy and their response to oestrogen therapy. South Afr Med J 1972;46: 732-7

40. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977-4:31-47

41. Soares CN, al Maida OP, Joffe E, Cohen LS. Efficacy of oestradiol for the treatment of depressive disorders in perimenopausal women: a double blind randomised placebo controlled trial. Arch Gen Psychiatry 2001;58:529-34

42. Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal woman. J Clin Psychiatry 2002;63(Suppl 7): 545-8

43. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and cycles. Arch Gen Psychiatry 2003;60:29-36

44. Miller KJ. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers. Curr Psychiatry Rep 2003;5:439-44

45. Smith RN, Holland ES, Studd JWW. The symptomatology of progestogen intolerance. Maturitas 1994;18:87-91

46. Panay N, Studd JWW. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71

47. Watson NR, Studd JWW, Savvas M, Baber R. The longterm effects of oestrogen implant therapy for the treatment of premenstrual syndrome. Gynaecol Endocrinol 1990;4:99-107